32% of firms lack social media plan

Share this article:
Two-thirds of life science company executives use social networking or plan to on behalf of their companies, a recent Deloitte survey said. Thirty-five percent said they have no plans to do so.
Around 44% said they have an informal strategy for social networking that is not documented or fully supported by leadership, and 32% have no strategy at all.
Many cited FDA's lack of clarity when asked what was holding them back. Thirty-eight percent said they're waiting for FDA guidance on social networking before making any investment, while 28% said they're waiting to see what return on investment other firms get.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"